Fusion Pharmaceuticals Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Fusion Pharmaceuticals Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2019 to Q1 2024.
  • Fusion Pharmaceuticals Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $4.52M, a 43.4% increase year-over-year.
  • Fusion Pharmaceuticals Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $13.8M, a 21.6% increase year-over-year.
  • Fusion Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2023 was $12.4M, a 14.8% increase from 2022.
  • Fusion Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2022 was $10.8M, a 26% increase from 2021.
  • Fusion Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2021 was $8.6M, a 155% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $13.8M $4.52M +$1.37M +43.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $12.4M $3.26M +$477K +17.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-20
Q3 2023 $12M $2.99M +$297K +11% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $11.7M $3.05M +$310K +11.3% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $11.4M $3.15M +$516K +19.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $10.8M $2.78M +$412K +17.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-20
Q3 2022 $10.4M $2.7M +$323K +13.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $10.1M $2.74M +$591K +27.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $9.52M $2.63M +$915K +53.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $8.6M $2.37M +$1.02M +76.2% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 $7.58M $2.37M +$1.13M +91.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $6.45M $2.15M +$1.72M +404% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $4.73M $1.72M +$1.36M +380% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $3.37M $1.34M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-17
Q3 2020 $1.24M +$1.1M +799% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $426K +$338K +384% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $358K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q3 2019 $138K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $88K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.